About Isis Outcomes

Isis Outcomes is an activity within Technology Transfer, part of Isis Innovation Limited, the Technology Transfer Company for the University of Oxford. Isis Outcomes is dedicated to the provision of high quality PROs and assistance with their use. Isis Outcomes provides licence rights (© licences) to its portfolio of PROs to the pharmaceutical sector, healthcare providers (both public and private), medical device companies and academic sector.

Isis Outcomes has a portfolio of PRO measures covering neurological disorders, obstetrics and gynecology, as well as outcome measures directed at orthopedic intervention assessments. These PROs have been developed at Oxford by our scientific team of experts in this field.

The team behind our renowned PROs is also able to provide you with expert consultant advice and support to help you get the most out of your PRO data and ensure it meets the requirements of the regulatory agencies. The Isis Outcomes team can also advise on the design, development, validation, or modification of PROs for conditions not yet covered by our current portfolio.

Our experts have extensive experience of developing and validating outcome measures and, in collaboration with others, conducting randomised controlled trials in which such PROs have been used as end-points. So, whether you are a pharmaceutical company, CRO or healthcare provider, we invite you to explore with us how the Isis Outcomes team can help you optimize your PRO activities.

Isis Outcomes strives to deliver the provision of rights to its PROs in a fast efficient manner giving customers the licence rights they need for their clinical study. We support this activity with our own PRO library management activities. Our PRO library activities ensure that any PROs provided by us have been translated and linguistically validated using industry best practice. The best practices we use are consistent with the guidelines provided by organisations such as ISPOR and regulatory organizations, such as the FDA. Isis Outcomes can also provide additional information in support of your use of our PROs, for example user manuals and development dossiers for FDA marketing label submissions.